MoneyWorks4Me

JHS Svendgaard Laboratories Ltd (JHS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532771 NSE: JHS Household & Personal Products | Small Cap | JHS Svendgaard Labs. Share Price

₹8.75 0.23 (2.70%)

As on 28-Sep'26 16:59

JHS Svendgaard Laboratories Ltd (JHS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532771 NSE: JHS Household & Personal Products | Small Cap | JHS Svendgaard Labs. Share Price

₹8.75 0.23 (2.70%)

As on 28-Sep'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹76 Cr.
Current Price
₹8.8
52-Week Low / High
₹6 / 14
TTM EPS
₹-0.2
TTM Sales
₹109 Cr.
Book Value per Share
₹20.1
P/E Ratio
0.00
Industry PE
41.8
Price to Book (P/B)
0.44
Lower than its 5-year historical median
Price to Sales (P/S)
0.70
Lower than its 5-year historical median
EV/EBITDA
12.97
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
-1.12%
Underperforms industry median
Return on Capital Employed (ROCE)
-0.78%
Underperforms industry median
Return on Assets (ROA)
-0.94%
Operating Profit Margin
2.6%
Net Profit Margin
-1.89%
Gross Profit Margin
5.1%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
10.53%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
33.85%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹88 Cr.
Equity
₹87.4 Cr.
Face Value
₹10
All Time Low / High
₹4.35 / 128.45

JHS Svendgaard Laboratories stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is JHS Svendgaard Laboratories Ltd a good quality company?
JHS Svendgaard Laboratories Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does JHS Svendgaard Laboratories Ltd performance compare with that of its Peers?
Q.1 Revenue growth of JHS Svendgaard Laboratories Ltd vs industry peers?
JHS Svendgaard Laboratories Ltd revenue CAGR is 0.18%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of JHS Svendgaard Laboratories Ltd?
Promoters hold 33.85% of the JHS Svendgaard Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of JHS Svendgaard Laboratories Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -13.2% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
JHS Svendgaard Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ4.8%26.5%3.4%1.7%2%1.3%-12.3%-1.7%-6.8%-0.8%-
Value Creation
Index ⓘ
-0.70.9-0.8-0.9-0.9-0.9-1.9-1.1-1.5-1.1-

Growth Parameters ⓘ

Sales ⓘ1051381201339779.984.870.892102109
Sales YoY Gr.-31.7%-13.5%11.1%-27.1%-17.6%6.1%-16.5%29.9%10.5%-
Adj EPS ⓘ51.30.60.80.5-0.5-0.7-0.5-2.1-0.2-0.2
YoY Gr.--73.5%-53.8%32.8%-38.3%-190%NANANANA-
BVPS (₹) ⓘ29.52929.529.829.729.222.221.719.92020.2
Adj Net
Profit ⓘ
2283.74.93.2-2.9-5.2-4-17.8-2.1-2
Cash Flow from Ops. ⓘ-3.913.2-10.115.115.4-11.323.3-8.6-5-2.7-
Debt/CF from Ops. ⓘ-0.60.2-0.700-0.10-0.4-1-5.6-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ-0.4%1%6.2%10.5%
Adj EPS ⓘ-171.4%-186.4%NANA
BVPSⓘ-4.2%-7.6%-3.4%0.6%
Share Price -12.4% -18.7% -26.5% -19%

Key Financial Parameters ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ
18.65.22.12.71.7-1.5-2.8-2.3-10.4-1.2-1.1
Op. Profit
Mgn % ⓘ
11.212.26.87.14.60.2-10.7-1.1-4.42.62.8
Net Profit
Mgn % ⓘ
20.95.83.13.73.3-3.6-6.1-5.6-19.3-2.1-1.8
Debt to
Equity ⓘ
0000000000.1-
Working Cap
Days ⓘ
206222352363470517442441331321103
Cash Conv.
Cycle ⓘ
18481071382121495353474656

Valuation of JHS Svendgaard Labs. - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales105.06140.29124.11139.11100.7786.2584.8170.8092101.69
Operating Expenses ⓘ + 93.37126.54124.70137.4498.8587.0993.8971.7396.0199.08
Manufacturing Costs36.0646.0233.1135.7333.3830.9136.2328.0239.6843.34
Material Costs40.8056.8963.9174.3345.5338.9637.0126.1734.9837.46
Employee Cost 8.6612.1013.5213.4410.0811.4510.199.2110.1211.25
Other Costs ⓘ 7.8411.5314.1613.949.855.7810.468.3311.237.03
Operating Profit ⓘ 11.6913.76-0.591.671.92-0.84-9.07-0.94-4.012.62
Operating Profit Margin (%) 11.1%9.8%-0.5%1.2%1.9%-1.0%-10.7%-1.3%-4.4%2.6%
Other Income ⓘ + 0.434.986.6613.837.549.3911.324.312.883.45
Exceptional Items ⓘ -0.0127.240-10.6400-18.630-2.860
Interest ⓘ 0.620.741.031.951.241.390.550.460.570.86
Depreciation ⓘ 6.366.817.098.767.257.056.026.357.957.50
Profit Before Tax ⓘ 5.1438.42-2.05-5.840.970.10-22.95-3.43-12.51-2.29
Tax ⓘ -16.8012.37-0.38-0.99-0.374.39-5.430.637.24-0.37
Profit After Tax 21.9426.05-1.67-4.861.34-4.29-17.52-4.06-19.74-1.92
PAT Margin (%) 20.9%18.6%-1.3%-3.5%1.3%-5.0%-20.7%-5.7%-21.5%-1.9%
Adjusted EPS (₹)5.04.3-0.1-0.30.2-0.6-2.2-0.5-2.3-0.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 129.75174.27176.61178188.45185.90173.84169.88170.23174.67
Share Capital ⓘ 44.1260.9060.9060.9064.4064.9078.4078.4085.6087.41
Reserves ⓘ 85.63113.36115.71117.10124.0512195.4491.4984.6287.26
Debt +0.741.105.810.520.470.480.240.124.9913.02
Long Term Debt0.651.100.810.520.470.480.240.120.695.52
Short Term Debt0.1005000004.307.51
Minority Interest-0.01-0.13.796.69.279.140000
Trade Payables13.9723.7223.2136.1215.9813.8419.9914.1013.4417.86
Others Liabilities ⓘ -6.054.356.789.173.795.7122.882.439.225.63
Total Liabilities ⓘ 138.42203.34216.21230.41217.95215.08216.95186.53197.88211.18

Fixed Assets

Net Fixed Assets ⓘ +6571.4170.8165.6363.2258.5265.0790.4190.3389.30
Gross Block71.3284.3690.6985.6988.9791.28101.48133.18133.59139.80
Accumulated Depreciation6.3212.9519.8720.0625.7532.7636.4242.7643.2750.50
CWIP ⓘ 0.670.514.807.058.9219.968.570.8203.98
Investments ⓘ 1.0318.199.756.032.053.622.973.453.645.10
Inventories10.729.549.025.6111.6412.101312.6511.8815.17
Trade Receivables13.6642.7353.8196.1558.7118.1218.5412.8813.0616.76
Cash Equivalents 5.866.311.070.9321.156.4638.6510.3619.5419.10
Others Assets ⓘ 41.4754.6566.9549.0152.2796.3070.1655.9659.4361.78
Total Assets ⓘ 138.42203.34216.21230.41217.95215.08216.95186.53197.88211.18
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + -3.9313.80-10.7910.3512.03-9.1423.29-9.18-5.18-2.66
PBT ⓘ 5.1411.18-2.054.790.970.10-22.95-3.43-12.51-2.29
Adjustment ⓘ 5.164.905.162.766.450.1822.585.7311.875.55
Changes in Working Capital ⓘ -14.19-26.72-13.1113.275.39-9.1123.65-11.61-4.26-5.28
Tax Paid ⓘ -0.04-2.80-0.790.17-0.77-0.3100.13-0.28-0.63
Cash Flow From Investing Activity ⓘ + -3.36-27.02-6.87-10.97-2.23-4.709.68-21.14-20.25-11.68
Capex -12.72-10.38-15.58-13.95-6.60-6.40-13.97-31.48-10.03-8.16
Net Investments 9.24-15.3313.283.944.06-0.40-0.72-0.300.17-1
Others ⓘ 0.12-1.31-4.57-0.950.312.1124.3710.64-10.39-2.51
Cash Flow From Financing Activity ⓘ + 10.1113.6312.530.4910.31-1.67-0.902.1723.0711.34
Net Proceeds from Shares ⓘ 13.0918.46010.3911.50000203.75
Net Proceeds from Borrowing ⓘ -0.780.46-0.29-1.35-0.020.01-0.14-0.120.574.83
Interest Paid ⓘ -0.65-0.56-0.89-1.89-0.63-1.01-0.24-0.41-0.23-0.80
Dividend Paid ⓘ 0000000000
Others ⓘ -1.54-4.7213.71-6.66-0.54-0.67-0.512.712.733.56
Net Cash Flow ⓘ 2.830.42-5.13-0.1320.11-15.5032.06-28.14-2.36-2.99
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)19.5317.15-0.95-2.740.76-2.36-9.75-2.36-11.61-1.12
ROCE (%)4.825.01-0.56-2.151.240.82-12.43-1.71-6.8-0.78
Asset Turnover Ratio0.810.830.590.630.450.40.390.350.480.5
PAT to CFO Conversion(x)-0.180.53N/AN/A8.98N/AN/AN/AN/AN/A
Working Capital Days
Receivable Days35.7072.10141.80195.50280162.6078.908151.5053.50
Inventory Days34.8025.9027.3019.1031.2050.205466.1048.7048.50
Payable Days122.20120.90134145.70208.80139.70166.90237.70143.70152.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

JHS Svendgaard Laboratories Ltd FAQs

The current trading price of JHS Svendgaard Labs. on 28-Sep-2026 16:59 is ₹8.75.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of JHS Svendgaard Labs. stood at ₹76.48 Cr

The latest P/E ratio of JHS Svendgaard Labs. as of 27-Sep-2026 is 0.00.

The latest P/B ratio of JHS Svendgaard Labs. as of 27-Sep-2026 is 0.43.

The 52-week high of JHS Svendgaard Labs. is ₹13.83 and the 52-week low is ₹6.15.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JHS Svendgaard Labs. is ₹109 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that JHS Svendgaard Laboratories Ltd is a below average quality company.

The key valuation ratios of JHS Svendgaard Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of JHS Svendgaard Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About JHS Svendgaard Laboratories Ltd

J H S Svendgaard Laboratories Ltd. started 12 years back in August 1997 as Sunehari Svendgaard Laboratories Limited, wherein it started functioning as a small scale enterprise. While, the breakthrough in company's history came with its incorporation as JHS Svendgaard Laboratories Limited on October 8, 2004.The main portfolio of the company was to carry out  export, import, trading, buying and selling of oral care/hygiene products (including toothbrushes and toothpastes).

It is an oral care products manufacturing company , manufacturing a wide variety of dental and oral products as contract manufacturer for many of the national and international brand names. Initially we manufactured only toothbrushes but realizing the vast potential of the oral care market, we also decided to venture into manufacturing of other dental care products like toothpastes, Mouthwash, Denture tablets etc.

The company took over the business from three propriety concerns namely Sunehari Svendgaard Laboratories, Sunehari Oral Care and Jai Hanuman Exports with effect from April 1, 2005.

On October 2007, as a diversification plan  , JHS ventured in uprising  Dental care service sector through its wholly owned subsidiary , JHS Svendgaard Dental care Limited .Its purpose is to set up state-of-art dental clinics in brand name of T 32 Dental Spa across the country. The service provided in the centers spans between the general and restorative dentistry up to hi-end cosmetic procedures i.e. A to Z of  Dental treatment and oral care. The two initial centers of T 32 were inaugurated in South Delhi and the chain is expanding with more upcoming clinics in Delhi NCR in initial phases followed by its spread across the country  .

To add  more fruits to its basket,  it thought of using the experience in the oral care industry and encash the market opportunities ,so on April 2009 it launched its own brand Dr. Gold .It started with market activation in 20 major cities of the country. It has  begun with toothbrushes (in all, economy, mid economy and premium range), while, other related oral care products and personal care products (Shaving gels, shampoos etc) would be added to our mother brand in the near future.

The success of JHS is the saga of teamwork. The role-played by their customers who are BIG Brands globally in providing us inputs on technological front helps us to grow at this pace and be internationally competitive.

JHS created a distinct image for the fundamental dental hygiene products. They have concretized a brand status to activity like contract manufacturing, instilling in it a faith that our customers can identify with then give us their brands to manufacture with them.

Hence, they are in the business of not building brands but taking care and growing global brands by providing them products to match their requirements. Their core competence is in the oral and dental care segment and they shall continue to stick to their capabilities and enhance customer satisfaction in this particular area rather than diverting attention to other.

Fully Automatic Inspection Machine from Zahoransky ensures complete customer satisfaction as well as products matching the International specification.

Product range of the company includes:

Private labels:

  • Baby Products
  • Denture products
  • Power Products
  • Tooth Brushes
  • Toothpaste & Mouth-Rinse.

Achievements/ recognition:

  • ISO 9001:2000.
  • Top Exporter Award for Tooth Brushes, 2003-2004
  • Top Exporter Award for Tooth Brushes, 2004-2005 
  • Top Exporter Award for Tooth Brushes, 2005-2006    
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now